Ublituximab for the treatment of CD20 positive B-cell malignancies

  • Hani M. Babiker, Ashley E. Glode, Laurence S. Cooke, Daruka Mahadevan
  • Expert Opinion on Investigational Drugs, April 2018, Taylor & Francis
  • DOI: 10.1080/13543784.2018.1459560

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/13543784.2018.1459560